Medical Foods Market: By Therapeutic Type (Pain Management, Sleep Management, Obesity and Hypertension, Cognitive Disorders, Viral Infections, Neuro-Degenerative Disorders, Inborn Errors of Metabolism), By Mode of Administration (Parenteral, Enteral, Others), By Application (Diabetic Neuropathy, ADHD, Depression, Alzheimer's Disease, Nutritional Deficiency, Others), By Distribution Channel (Hospital Pharmacy, Retail pharmacy, and Online pharmacy) and Geography  

Purchase Option

$ 4400
$ 6600
$ 8900

Medical foods market size was valued at $ 17.03 Bn in 2022 and is anticipated to grow at $ 29.67 Bn by 2029 recording a CAGR of 6.5% from 2023-2029. Foods that are subjected to technological modifications either for protection or for changing over into prepared-to-utilize/eat nourishments, disposing of relentless family unit strategies, are called Medical Foods". A portion of the cases is processed blends, dried-out nourishments, pasta items, canned food, confectionery, pastry shop, dairy items, and breakfast nourishments. Manufacture of Medical Foods requires innovative applications and apparatus, and thus, Medical Foods are costly. Modern players are engaged with the securing of little players which will additionally bolster the organization to grow and contact shoppers over the areas, the end-client enterprises are slanted towards item advancements through online life, magazines, and different mediums keeping in mind the end goal to connect with clients. The limited time methodology helps in holding the current clients and furthermore to recover new client base. With vital extensions, advertise players can center around entering into the creating economies to extend their business portfolio. Customers in creating nations are excited about investigating new item runs offered to them and framing a substantial purchaser base. Setting up showcases in these rising economies is beneficial in view of moderately low set-up costs, simplicity of working together, and further lower variable cost to be caused.

Medical Foods Market Key Developments:
  • In November 2017 BASF SE teamed up with DIEM Labs to fortify the nearness in the U.S. and also, go into the therapeutic sustenances showcase. In November 2017 Ajinomoto obtained Cambrooke Therapeutics, Inc. keeping in mind the end goal to upgrade the item arrangement of therapeutic nourishments. Rising interest in therapeutic sustenances from the locale will encourage high-income age through this section.
  • In September 2017 Kellogg put resources into mushroom protein organization. Kellogg is a main player in the breakfast feast items. This will help in expanding the organization's income and will permit likewise to concoct excellent therapeutic vaccines supplements. Medical Foods Market is classified on the basis of Therapeutic Type, By Mode of Administration, Application, Distribution Channel, and geographical regions. 

Medical Foods Market Summary

Study Period

2024-2030

Base Year

2023

CAGR

6.5%

Largest Market

North America

Fastest Growing Market

Asia-Pacific
Medical Foods Market Dynamics

The worldwide Medical Foods market is driven by an ascent in geriatric populace and increment in risk of chronic ailments around the world. There is a moving pattern toward enteral nourishment (ingestion through the gastrointestinal tract) parenteral nutrition absorption such as intravenous administration, for example, intravenous organization. The enteral organization is more secure when contrasted with the parenteral choice as there is a lesser danger of disease and it offers physiological benefits, for example, the upkeep of small digestive system mass and pancreatic capacity. Mechanical progressions have decreased the cost of enteral medication organization, influencing it to cost-effective. Hence, a move toward medical food and increment in demand for customized prescription in created nations are relied upon to fuel interest for medicinal foods sooner rather than later.

Medical Foods Market Segmentation

By Therapeutic Type
  • Pain Management, Sleep Management
  • Obesity and Hypertension
  • Cognitive Disorders
  • Viral Infections
  • Neuro-Degenerative Disorders
  • Inborn Errors of Metabolism
By Route of Administrat
  • Parenteral
  • Enteral
  • Others
By Application
  • Diabetic Neuropathy
  • ADHD
  • Depression
  • Alzheimer’s Disease
  • Nutritional Deficiency
  • Others
By Distribution Channel
  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacy

Frequently Asked Questions

The medical foods market size was valued at $ 17.03 Bn in 2022.

The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).

In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.

The medical foods market key players are: Danone SA (France), Nestle SA (Switzerland), Abbott Laboratories (U.S.), Mead Johnson & Company, LLC (U.S.), Primus Pharmaceuticals Inc. (U.S.), Targeted Medical Pharma Inc. (U.S.), Fresenius Kabi AG (Germany)

Key Features of the Reports

  • The medical foods market report provides granular level information about the market size, regional market share, historic market (2018 to 2022), and forecast (2023 to 2029)
  • The report covers in-detail insights about the competitor's overview, company share analysis, key market developments, and key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments, and startup details that are actively working in the market
  • The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario
  • The report analyses the impact of the socio-political environment through PESTLE Analysis and competition through Porter's Five Force Analysis in addition to recent technology advancements and innovations in the market
1.Executive Summary
2.Global Medical Foods Market Introduction 
2.1.Global Medical Foods Market  - Taxonomy
2.2.Global Medical Foods Market  - Definitions
2.2.1.Therapeutic Type
2.2.2.Mode of Administration
2.2.3.Application
2.2.4.Distribution Channel
2.2.5.Region
3.Global Medical Foods Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Product Landscape
3.6. New Product Launches
3.7. Impact of COVID 19 on Market
4.Global Medical Foods Market Analysis, 2018-2022 and Forecast 2023-2029
4.1.  Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
4.2.  Year-Over-Year (Y-o-Y) Growth Analysis (%) 
4.3.  Market Opportunity Analysis 
5.Global Medical Foods Market  By Therapeutic Type, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
5.1. Pain Management, Sleep Management
5.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.1.3. Market Opportunity Analysis 
5.2. Obesity and Hypertension
5.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.2.3. Market Opportunity Analysis 
5.3. Cognitive Disorders
5.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.3.3. Market Opportunity Analysis 
5.4. Viral Infections
5.4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.4.3. Market Opportunity Analysis 
5.5. Neuro-Degenerative Disorders
5.5.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
5.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.5.3. Market Opportunity Analysis 
5.6. Inborn Errors of Metabolism
5.6.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
5.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.6.3. Market Opportunity Analysis 
6.Global Medical Foods Market  By Mode of Administration, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
6.1. Parenteral
6.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.1.3. Market Opportunity Analysis 
6.2. Enteral
6.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.2.3. Market Opportunity Analysis 
6.3. Others
6.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.3.3. Market Opportunity Analysis 
7.Global Medical Foods Market  By Application, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
7.1. Diabetic Neuropathy
7.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.1.3. Market Opportunity Analysis 
7.2. ADHD
7.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.2.3. Market Opportunity Analysis 
7.3. Depression
7.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.3.3. Market Opportunity Analysis 
7.4. Alzheimers Disease
7.4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.4.3. Market Opportunity Analysis 
7.5. Nutritional Deficiency
7.5.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
7.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.5.3. Market Opportunity Analysis 
8.Global Medical Foods Market  By Distribution Channel, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
8.1. Hospital Pharmacy
8.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.1.3. Market Opportunity Analysis 
8.2. Retail Pharmacy
8.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.2.3. Market Opportunity Analysis 
8.3. Online Pharmacy
8.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.3.3. Market Opportunity Analysis 
9.Global Medical Foods Market  By Region, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
9.1. North America
9.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
9.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.1.3. Market Opportunity Analysis 
9.2. Europe
9.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
9.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.2.3. Market Opportunity Analysis 
9.3. Asia Pacific (APAC)
9.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
9.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.3.3. Market Opportunity Analysis 
9.4. Middle East and Africa (MEA)
9.4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
9.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.4.3. Market Opportunity Analysis 
9.5. Latin America
9.5.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
9.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.5.3. Market Opportunity Analysis 
10.North America Medical Foods Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
10.1. Therapeutic Type Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.1.1.Pain Management, Sleep Management
10.1.2.Obesity and Hypertension
10.1.3.Cognitive Disorders
10.1.4.Viral Infections
10.1.5.Neuro-Degenerative Disorders
10.1.6.Inborn Errors of Metabolism
10.2.  Mode of Administration Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.2.1.Parenteral
10.2.2.Enteral
10.2.3.Others
10.3.  Application Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.3.1.Diabetic Neuropathy
10.3.2.ADHD
10.3.3.Depression
10.3.4.Alzheimer’s Disease
10.3.5.Nutritional Deficiency
10.4.  Distribution Channel Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.4.1.Hospital Pharmacy
10.4.2.Retail Pharmacy
10.4.3.Online Pharmacy
10.5.  Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.5.1.United States of America (USA)
10.5.2.Canada
11.Europe Medical Foods Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
11.1. Therapeutic Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.1.1.Pain Management, Sleep Management
11.1.2.Obesity and Hypertension
11.1.3.Cognitive Disorders
11.1.4.Viral Infections
11.1.5.Neuro-Degenerative Disorders
11.1.6.Inborn Errors of Metabolism
11.2.  Mode of Administration Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.2.1.Parenteral
11.2.2.Enteral
11.2.3.Others
11.3.  Application Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.3.1.Diabetic Neuropathy
11.3.2.ADHD
11.3.3.Depression
11.3.4.Alzheimer’s Disease
11.3.5.Nutritional Deficiency
11.4.  Distribution Channel Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.4.1.Hospital Pharmacy
11.4.2.Retail Pharmacy
11.4.3.Online Pharmacy
11.5.  Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.5.1.Germany
11.5.2.France
11.5.3.Italy
11.5.4.United Kingdom (UK)
11.5.5.Spain
11.5.6.Rest of EU
12.Asia Pacific (APAC) Medical Foods Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
12.1. Therapeutic Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.1.1.Pain Management, Sleep Management
12.1.2.Obesity and Hypertension
12.1.3.Cognitive Disorders
12.1.4.Viral Infections
12.1.5.Neuro-Degenerative Disorders
12.1.6.Inborn Errors of Metabolism
12.2.  Mode of Administration Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.2.1.Parenteral
12.2.2.Enteral
12.2.3.Others
12.3.  Application Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.3.1.Diabetic Neuropathy
12.3.2.ADHD
12.3.3.Depression
12.3.4.Alzheimers Disease
12.3.5.Nutritional Deficiency
12.4.  Distribution Channel Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.4.1.Hospital Pharmacy
12.4.2.Retail Pharmacy
12.4.3.Online Pharmacy
12.5.  Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.5.1.China
12.5.2.India
12.5.3.Australia and New Zealand (ANZ)
12.5.4.Japan
12.5.5.Rest of APAC
13.Middle East and Africa (MEA) Medical Foods Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
13.1. Therapeutic Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.1.1.Pain Management, Sleep Management
13.1.2.Obesity and Hypertension
13.1.3.Cognitive Disorders
13.1.4.Viral Infections
13.1.5.Neuro-Degenerative Disorders
13.1.6.Inborn Errors of Metabolism
13.2.  Mode of Administration Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.2.1.Parenteral
13.2.2.Enteral
13.2.3.Others
13.3.  Application Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.3.1.Diabetic Neuropathy
13.3.2.ADHD
13.3.3.Depression
13.3.4.Alzheimers Disease
13.3.5.Nutritional Deficiency
13.4.  Distribution Channel Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.4.1.Hospital Pharmacy
13.4.2.Retail Pharmacy
13.4.3.Online Pharmacy
13.5.  Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.5.1.GCC Countries
13.5.2.South Africa
13.5.3.Rest of MEA
14.Latin America Medical Foods Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
14.1. Therapeutic Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.1.1.Pain Management, Sleep Management
14.1.2.Obesity and Hypertension
14.1.3.Cognitive Disorders
14.1.4.Viral Infections
14.1.5.Neuro-Degenerative Disorders
14.1.6.Inborn Errors of Metabolism
14.2.  Mode of Administration Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.2.1.Parenteral
14.2.2.Enteral
14.2.3.Others
14.3.  Application Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.3.1.Diabetic Neuropathy
14.3.2.ADHD
14.3.3.Depression
14.3.4.Alzheimer’s Disease
14.3.5.Nutritional Deficiency
14.4.  Distribution Channel Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.4.1.Hospital Pharmacy
14.4.2.Retail Pharmacy
14.4.3.Online Pharmacy
14.5.  Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.5.1.Brazil
14.5.2.Mexico
14.5.3.Rest of LA
15. Competition Landscape
15.1.  Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) 
15.2.1.Danone SA (France)
15.2.2.Nestle SA (Switzerland)
15.2.3.Abbott Laboratories (U.S.)
15.2.4.Mead Johnson & Company, LLC (U.S.)
15.2.5.Primus Pharmaceuticals Inc.
15.2.6.Targeted Medical Pharma Inc. (U.S.)
15.2.7.Fresenius Kabi AG (Germany)
16. Research Methodology 
17. Appendix and Abbreviations 
  • Danone SA (France)
  • Nestle SA (Switzerland)
  • Abbott Laboratories (U.S.)
  • Mead Johnson & Company, LLC (U.S.)
  • Primus Pharmaceuticals Inc. (U.S.)
  • Targeted Medical Pharma Inc. (U.S.)
  • Fresenius Kabi AG (Germany)

Adjacent Markets